Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Cancer Treatment Reports
|
June 1, 1980
Treatment of advanced endometrial adenocarcinoma with tamoxifen
K D Swenerton
Acta Obstetricia Et Gynecologica Scandinavica. Supplement
|
January 1, 1992
Prognostic indices in ovarian cancer. Their significance in treatment planning
K D Swenerton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Oral etoposide is active against platinum-resistant epithelial ovarian cancer
P J Hoskins, K D Swenerton
Seminars in Oncology
|
February 1, 1992
Carboplatin in the treatment of carcinoma of the ovary: the National Cancer Institute of Canada experience. Ovarian Cancer Subcommittee
K D Swenerton, J L Pater
American Journal of Clinical Oncology
|
October 1, 1990
A phase II trial of mitomycin in patients with epithelial ovarian carcinoma resistant to cisplatin or carboplatin
P J Hoskins, E McMurtrie, K D Swenerton
American Journal of Clinical Oncology
|
June 1, 1996
Taxol is active in platinum-resistant endometrial adenocarcinoma
H L Woo, K D Swenerton, P J Hoskins
Cancer
|
June 1, 1994
Endometrial adenocarcinoma presenting as an isolated calcaneal metastasis. A rare entity with good prognosis
J K Cooper, F L Wong, K D Swenerton
The New England Journal of Medicine
|
July 12, 1979
Treatment of advanced endometrial carcinoma with tamoxifen
K D Swenerton, G W White, D A Boyes
Gynecologic Oncology
|
May 21, 2005
Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience
A V Tinker, K Bhagat, K D Swenerton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 1, 1997
Gliomatosis peritonei with malignant transformation
F Dadmanesh, D M Miller, K D Swenerton, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Cancer Treatment Reports
|
June 1, 1980
Treatment of advanced endometrial adenocarcinoma with tamoxifen
K D Swenerton
Acta Obstetricia Et Gynecologica Scandinavica. Supplement
|
January 1, 1992
Prognostic indices in ovarian cancer. Their significance in treatment planning
K D Swenerton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Oral etoposide is active against platinum-resistant epithelial ovarian cancer
P J Hoskins, K D Swenerton
Seminars in Oncology
|
February 1, 1992
Carboplatin in the treatment of carcinoma of the ovary: the National Cancer Institute of Canada experience. Ovarian Cancer Subcommittee
K D Swenerton, J L Pater
American Journal of Clinical Oncology
|
October 1, 1990
A phase II trial of mitomycin in patients with epithelial ovarian carcinoma resistant to cisplatin or carboplatin
P J Hoskins, E McMurtrie, K D Swenerton
American Journal of Clinical Oncology
|
June 1, 1996
Taxol is active in platinum-resistant endometrial adenocarcinoma
H L Woo, K D Swenerton, P J Hoskins
Cancer
|
June 1, 1994
Endometrial adenocarcinoma presenting as an isolated calcaneal metastasis. A rare entity with good prognosis
J K Cooper, F L Wong, K D Swenerton
The New England Journal of Medicine
|
July 12, 1979
Treatment of advanced endometrial carcinoma with tamoxifen
K D Swenerton, G W White, D A Boyes
Gynecologic Oncology
|
May 21, 2005
Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience
A V Tinker, K Bhagat, K D Swenerton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 1, 1997
Gliomatosis peritonei with malignant transformation
F Dadmanesh, D M Miller, K D Swenerton, et al.
Page
of 4